Franklin Resources Inc. Grows Stake in Ardent Health Partners, LLC (NYSE:ARDT)

Franklin Resources Inc. lifted its position in Ardent Health Partners, LLC (NYSE:ARDT - Free Report) by 9.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 917,926 shares of the company's stock after buying an additional 78,575 shares during the period. Franklin Resources Inc. owned about 0.64% of Ardent Health Partners worth $15,678,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in ARDT. US Bancorp DE bought a new position in Ardent Health Partners in the 4th quarter valued at approximately $31,000. R Squared Ltd purchased a new position in shares of Ardent Health Partners in the fourth quarter worth $37,000. BNP Paribas Financial Markets bought a new position in shares of Ardent Health Partners during the third quarter valued at $42,000. New York State Common Retirement Fund bought a new position in shares of Ardent Health Partners during the fourth quarter valued at $48,000. Finally, MetLife Investment Management LLC bought a new stake in Ardent Health Partners in the 3rd quarter worth about $135,000.

Wall Street Analysts Forecast Growth

ARDT has been the topic of a number of recent analyst reports. Stephens reaffirmed an "overweight" rating and set a $22.00 price target on shares of Ardent Health Partners in a report on Tuesday, April 1st. Truist Financial dropped their target price on shares of Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Guggenheim initiated coverage on shares of Ardent Health Partners in a research report on Wednesday. They issued a "buy" rating and a $16.00 target price for the company. Morgan Stanley lowered their price target on Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating on the stock in a report on Tuesday, January 21st. Finally, Royal Bank of Canada cut their price objective on Ardent Health Partners from $23.00 to $21.00 and set an "outperform" rating for the company in a report on Tuesday, March 4th. Two analysts have rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Buy" and an average target price of $20.58.

Remove Ads

Ardent Health Partners Stock Performance

Shares of ARDT stock traded down $0.35 during trading hours on Friday, reaching $11.76. 244,757 shares of the company traded hands, compared to its average volume of 406,304. The firm has a 50-day moving average price of $13.86 and a 200 day moving average price of $15.77. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78. Ardent Health Partners, LLC has a 12-month low of $11.60 and a 12-month high of $20.72.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.31. The firm had revenue of $1.61 billion for the quarter, compared to analysts' expectations of $1.48 billion. On average, analysts anticipate that Ardent Health Partners, LLC will post 1.23 earnings per share for the current year.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.